Home
Zenlabs Ethica Ltd Share Price History
Zenlabs Ethica Ltd
BSE : 06 Feb, 2025
35.511.1 (3.3%)
Prev Close
34.4
Open Price
35.8
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
2008
Today's High / Low
35.8 / 35.0
52 WK High / Low
52.4 / 32.8
Market Price of Zenlabs Ethica Ltd
1M
1Y
3Y
5Y
Monitoring Zenlabs Ethica Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 81 |
| Sales YoY Gr. | - |
| Adj EPS | 1.53 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 9.34 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 18.05 |
| Op. Profit Mgn % | 1.89 |
| Net Profit Mgn % | 1.17 |
| Debt to Equity % | 0.19 |
Latest Shareholding
Promoters Holdings Over Time
About Zenlabs Ethica Ltd
- Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
- The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
- It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
- The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
- Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.
FAQs for Zenlabs Ethica Ltd Share Price History
What are the key events that typically impact Zenlabs Ethica Ltd's share price history?
Key events that impact Zenlabs Ethica Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Zenlabs Ethica Ltd's share price history?
Stock splits reduce the nominal price of Zenlabs Ethica Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Zenlabs Ethica Ltd?
Dividends can influence Zenlabs Ethica Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Zenlabs Ethica Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Zenlabs Ethica Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Zenlabs Ethica Ltd’s share price history?
To understand Zenlabs Ethica Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
